Professor | Shengtian Li | Asia Growth Partners

Name

Shengtian Li

Contact Information

lstian@sjtu.edu.cn

Language ability

Chinese, English

Province

Shanghai

University/Lab Affiliation and Title	Shanghai Jiao Tong University
Faculty	Life Sciences
Academic Background & Achievements	PhD in Neurobiology from the University of Tokyo Recognized as Shanghai Pujiang Talent Recipient of the Second Prize of Shanghai Science and Technology Progress Award
Work Experience	Current - Shanghai Jiao Tong University, Associate Professor
Awards	2006: Shanghai Pujiang Talent Program support 2019: Second Prize of Shanghai Science and Technology Progress Award

University/Lab Affiliation and Title

Shanghai Jiao Tong University

Faculty

Life Sciences

Academic Background & Achievements

Work Experience

Awards

Areas of Focus	Pathogenesis and treatment development for psychiatric and neurological disorders such as epilepsy and Parkinson's disease
Publications	Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson's disease, Shengtian Li Protective effects of β-nicotinamide adenine dinucleotide against motor deficits and dopaminergic neuronal damage in a mouse model of Parkinson’s disease, Shengtian Li Osteocalcin ameliorates cognitive dysfunctions in a mouse model of Alzheimer’s Disease by reducing amyloid β burden and upregulating glycolysis in neuroglia., Shengtian Li Kininogen level in the cerebrospinal fluid may be a potential biomarker for predicting epileptogenesis, Shengtian Li Antidepressant-like Effect of Low-intensity Transcranial Ultrasound Stimulation, Shengtian Li Osteocalcin ameliorates motor dysfunction in a 6-hydroxydopamine hydrobromide-induced Parkinson’s disease rat model through AKT/GSK3β signaling, Shengtian Li PHF8 histone demethylase deficiency causes cognitive impairments through the mTOR pathway, Shengtian Li Nicotinamide adenine dinucleotide suppresses epileptogenesis at an early stage, Shengtian Li Synaptic and Extrasynaptic Glutamate Signaling in Ischemic Stroke, Shengtian Li

Areas of Focus

Pathogenesis and treatment development for psychiatric and neurological disorders such as epilepsy and Parkinson's disease

Publications

Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson's disease, Shengtian Li
Protective effects of β-nicotinamide adenine dinucleotide against motor deficits and dopaminergic neuronal damage in a mouse model of Parkinson’s disease, Shengtian Li
Osteocalcin ameliorates cognitive dysfunctions in a mouse model of Alzheimer’s Disease by reducing amyloid β burden and upregulating glycolysis in neuroglia., Shengtian Li
Kininogen level in the cerebrospinal fluid may be a potential biomarker for predicting epileptogenesis, Shengtian Li
Antidepressant-like Effect of Low-intensity Transcranial Ultrasound Stimulation, Shengtian Li
Osteocalcin ameliorates motor dysfunction in a 6-hydroxydopamine hydrobromide-induced Parkinson’s disease rat model through AKT/GSK3β signaling, Shengtian Li
PHF8 histone demethylase deficiency causes cognitive impairments through the mTOR pathway, Shengtian Li
Nicotinamide adenine dinucleotide suppresses epileptogenesis at an early stage, Shengtian Li
Synaptic and Extrasynaptic Glutamate Signaling in Ischemic Stroke, Shengtian Li

Epilepsy Parkinson'S Disease Neurology Pathogenesis Treatment Neurological Disorders Psychiatric Disorders Research Development Intervention

Shi Jiejun - Tongji University

Yinghui Zhu - Tongji University

Wen Chen - Tongji University

View All

Personal Information